NA bases are constantly damaged by factors such as reactive oxygen species, chemotoxic agents, ionizing radiation and UV radiation 1 , and are subject to physiological modification by enzymes such as activation-induced cytidine deaminase, DNA methylases and the ten-eleven translocation enzymes 2, 3 . These types of DNA alterations are primarily repaired by the base excision repair pathway, which is initiated by DNA glycosylases that recognize and cleave damaged or modified bases, creating apurinic or apyrimidinic sites (AP sites), also known as abasic sites 1 . HMCES was recently reported to recognize and covalently cross-link to abasic sites in single-stranded DNA (ssDNA), generated by uracil-DNA glycosylase (UDG) at stalled replication forks 4 . The authors suggested that these DNA-protein cross-link (DPC) intermediates prevented ssDNA breaks that may consequently occur on cleavage by AP endonucleases, which could subsequently be repaired through error-prone pathways 4 . Human HMCES has a highly conserved amino (N)-terminal SOS response-associated peptidase domain (SRAPd) that is widely found in bacteria and eukaryotes, with a sporadic presence in certain bacteriophages and archaea 5 . Animal SRAP proteins have an additional carboxy (C)-terminal disordered extension with multiple copies of the PCNA-interacting motif (PIP) 4, 6 . Gene-neighborhood analysis in prokaryotes identified SRAPd as a novel component of the bacterial SOS response, associated with multiple components of the DNA-repair machinery 5 . The SRAPd contains a triad of predicted catalytic residues, namely Cys 2, Glu 127 and His 210, which are highly conserved across SRAP domains from all the three superkingdoms of life and viruses. This triad is predicted to support autoproteolytic activity acting on the peptide bond N-terminal to Cys 2, as all characterized SRAP proteins show cleavage of residues that are N-terminal to this cysteine 5 . Moreover, Cys 2 was recently shown to mediate the formation of the DPC via a covalent linkage to the deoxyribose at the abasic site of the DNA 4 . Here, we present the crystal structures of the human HMCES SRAP domain in DNAfree form and in complex with several 3′ overhang DNAs, including a DPC structure with an abasic site at the 3′ overhang. Through structure analysis and mutagenesis experiments we delineate the key residues of HMCES that are involved in DNA binding, revealing considerable flexibility in substrate recognition.
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Results
Crystal structures of the human HMCES SRAP domain in complex with 3′ overhang DNA. To better understand the mechanism of HMCES association with DNA, we crystallized the human HMCES SRAPd (residues 2-270) in its DNA-free form (Apo_SRAPd) and in complex with several DNA-damage substrates containing 3′ overhangs of different lengths. The crystal structure of SRAPd in complex with duplex DNA containing a three-nucleotide overhang at the 3′ end (referred to here as SRAPd_3nt) revealed SRAPd binding to two DNA molecules: DNA-A interacts via the 3′ overhang and another molecule (DNA-B) via the blunt-end (Fig. 1a) . Both DNA interaction surfaces are highly conserved.
SRAPd interacts with the 3′ overhang of DNA-A through a hydrophobic shelf created by Trp 81 and Phe 92, which form π-stacking interactions with the duplex segment of DNA at the ssDNA-dsDNA junction, which is referred to here as dsDNA-interaction site A (Fig. 1b,c) . At the same time, Arg 106 inserts into the minor groove of dsDNA, further stabilizing the complex. In Apo_SRAPd, Arg 106 is stacked onto Trp 81 instead of the nucleobase (Fig. 2a) . The ssDNA segment of the 3′ overhang is sharply bent by approximately 90 degrees and lies in a narrow, positively charged cleft directing it towards the catalytic triad. The ssDNA-binding cleft includes conserved Arg 98 and Arg 212, which form salt-bridges with the phosphate backbone of ssDNA (Fig. 1b,d of either of these arginine residues severely hinder ssDNA binding ( Supplementary Fig. 1 ), and are consistent with gel-shift assays reported by Mohni et al. 4 The pocket housing the catalytic triad accommodates the 3′-hydroxyl of the ssDNA overhang (Fig. 1d) . Interestingly, mutation of individual catalytic triad residues to alanine yielded SRAPd variants with higher affinity for ssDNA compared to wild-type protein, suggesting a role other than simply DNA binding ( Supplementary Fig. 1 ).
The SRAPd_3nt structure also revealed that the blunt-end of DNA-B interacts with SRAPd via dsDNA-interaction site B, composed of residues Gly 3, Arg 4, Pro 46, Asp 47, Trp 128 (Fig. 1e) . This interaction surface represents a potential binding site for 5′ overhang DNA, as SRAPd was shown to bind both 5′ and 3′ overhangs with similar affinities 4 . This dsDNA-interaction site B accounts for the remaining residues, which are highly conserved in SRAP domains across all superkingdoms of life and phages 5 , suggesting that it is a universal functional feature of this domain. It is immediately adjacent to the catalytic triad and forms a contiguous, similarly charged surface with the ssDNA-binding site (Fig. 1b) . These features suggested that dsDNA-interaction site B may also be able to accommodate ssDNA extending from a longer 3′ overhang substrate bound to the dsDNA-interaction site A.
To address this question, we determined the crystal structure of SRAPd with DNA containing a six-nucleotide overhang at the 3′ end The 3′ overhang DNA sequence that was used for co-crystallization is shown in the middle. b, Electrostatic surface potential representation of SRAPd interacting with two symmetry-related DNA molecules: DNA-A in green and orange, and DNA-B in magenta and yellow. SRAPd surface color indicates electrostatic potential ranging from −7 kT e −1 (red) to +7 kT e −1 (blue). Electrostatic surface potentials were calculated using APBS (referred to here as SRAPd_6nt). Although SRAPd has nearly tenfold higher affinity for ssDNA compared to dsDNA (Fig. 2d) , the longer 3′ overhang did not displace the blunt-end-interacting DNA-B from its dsDNA-interaction site B. Instead, the extra single-strand bases protrude out of the catalytic triad pocket (Fig. 2b) , and (Supplementary Fig. 2 ), suggesting that the dsDNA-interaction site B has specifically evolved to bind duplex DNA and may form the binding site for 5′ overhang DNA structures as well. Nevertheless, given that DNA is a mediator of the crystal lattice in this crystal form, we cannot entirely rule out that a longer ssDNA might occupy the dsDNA-interaction site B in the absence of a competing duplex DNA.
HMCES prefers ssDNA and 3-nucleotide gap DNA over intact dsDNA. In SRAPd_3nt, the distance between the 3′ end of DNA-A and the 5′ end of DNA-B at the catalytic triad is around 3.2 Å, which is sufficient to accommodate a phosphate group linking the two substrates together (Fig. 2c) . Consistent with our observations, the affinity of SRAPd to dsDNA with a 3-nucleotide gap is approximately sevenfold higher than intact dsDNA of the same sequence (Fig. 2d) . These data suggest the potential for binding other types of gapped DNA structures that form during DNA repair (Fig. 2e) , such as nucleotide excision repair intermediates. The Trp81Glu substitution at dsDNA-interaction site A, and Arg4Ala substitution at dsDNA-interaction site B, severely hindered SRAPd binding to 3-nucleotide gap DNA, suggesting that both interaction sites are crucial for substrate DNA binding ( Supplementary Fig. 1 ).
Crystal structure of the human HMCES SRAP domain crosslinked to DNA abasic site. To further investigate the covalent interaction of HMCES with a DNA abasic site, we crystallized the HMCES SRAP domain with 3′ overhang DNA (similar to that in SRAPd_6nt) having an abasic site at position 9 (AP9) of the longer strand (referred to here as SRAPd_DPC) (Fig. 3a) . To generate a physiologically relevant, reactive aldehydic form of the abasic site capable of cross-linking with HMCES, we designed the 3′ overhang to have a deoxyuridine (dU) at position 9 of the longer DNA strand, which is predicted to bind immediately adjacent to the Cys 2. We then treated this DNA with UDG to generate AP9 DNA 7 . For the cross-link reaction to proceed between the AP9 and Cys 2 of HMCES, the N-terminal methionine needs to be removed to expose the NH 2 of Cys 2. Mass spectrometric analysis of our purified C-terminally His-tagged SRAPd protein showed that the N-terminal methionine (Met 1) was cleaved, either cotranslationally, catalyzed by Escherichia coli methionyl-aminopeptidase 8 , or due to its predicted autopeptidase activity ( Supplementary  Fig. 3 Fig. 3 and Supplementary Table 1 ).
The SRAPd_DPC structure was refined to 2.2-Å resolution and is isomorphous with both the SRAPd_3nt and SRAPd_6nt structures. Continuous electron density was observed between Cys 2 of HMCES and the AP9, confirming the covalent cross-link (Fig. 3a,b) . The Cys 2-AP9 cross-link was modeled at full occupancy and shows approximately 20% higher B-factor values compared with its surrounding residues ( Table 1 ). The electron density map for the remaining three nucleotides downstream of the abasic site at the 3′ end was not resolved. Notably, the SRAPd_DPC structure suggests a model in which the terminal Cys 2 of HMCES reacts with the ring-opened aldehyde form of the abasic deoxyribose (AP9) to form a thiazolidine DNA-protein cross-link 9 ( Fig. 3a-c) . This crosslink entails an approximately 120° rotation around AP9γ 10 and possible hydrogen bonding between the 4′-hydroxyl of AP9 and the tau-nitrogen of His 210 (Fig. 3b,d ).
Discussion
HMCES was recently reported to promote genome stability by shielding abasic sites from error-prone repair pathways at stalled replication forks. In particular, Mohni et al. 4 showed that HMCES forms DPC intermediates with abasic sites in ssDNA generated by UDG, which is a monofunctional glycosylase that cannot cleave ssDNA. However, other variants of damaged bases require the use of bifunctional glycosylases with both glycosylase and lyase activities, such as NEIL3, which is a single-strand-specific glycosylase with a limited lyase activity able to cleave ssDNA 3′ to an abasic site to generate a 3′ overhang 11 . Our structures confirm this cross-link and reveal it to be a thiazolidine ring that involves both the side chain sulfur and the NH 2 of Cys 2 that is exposed by the peptidolytic removal of N-terminal methionine. Cys 2, along with Glu 127 and His 210, forms a predicted catalytic triad that is situated in a pocket characteristic of SRAP domains 5 . Thus, our structure reveals that, in addition to predicted autopeptidase activity, this pocket is also required for accommodation of the DPC. It also suggests that HMCES can recognize and covalently cross-link to DNA abasic sites at cleaved 3′ ends, which may shield them from further processing by exonucleases and regulate the choice between different DNA-repair pathways. The presence of two distinct dsDNA-interaction sites provides HMCES with flexibility to interact with abasic sites located at both 5′ and 3′ overhangs (Fig. 2e) . Because HMCES binds ssDNA, 3′ and 5′ overhangs, and 3-nucleotide gap DNA, it could be involved in a variety of DNA-repair pathways other than at stalled replication forks. For example, it could potentially be involved in physiological genome rearrangements such as class switch recombination in lymphocytes.
Our SRAPd structures also shed light on other proposed activities of HMCES. Proteomics studies using dsDNA baits with modified cytosines identified HMCES as a reader for oxidized 5-methyl-cytosines (oxi-mC) containing duplex DNA 12 . The SRAPd only contacts one base pair at the ssDNA-dsDNA junction (Fig. 1b) ; hence SRAPd of HMCES could potentially recognize a single oxi-mC either at this junction or alternatively in single-strand regions. Taken together, our structures support an important role for HMCES in recognizing and sensing flapped and gapped DNA-damage products and describe the covalent interaction of HMCES with DNA abasic sites, revealing its broad substrate recognition spectrum.
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Methods
Protein expression and purification. Wild-type and mutant HMCES variants were subcloned into pNIC-CH vector by modifying the C-terminal tag with a tobacco etch virus (TEV) cleavable C-terminal His 6 -tag, and were expressed in E. coli Rosetta. The recombinant proteins were first purified by nickel-affinity chromatography and, after TEV cleavage of the His 6 -tag, by anion exchange and gel-filtration chromatography using an S200 column. Purified SRAPd was concentrated to ~20 mg ml −1 in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine (TCEP). The sequences for all cloned constructs were verified by sequencing, and the corresponding molecular weights for all purified constructs were verified by liquid chromatography-mass spectrometry (LC-MS).
Crystallization and structural determination. Apo_SRAPd was crystallized using the sitting-drop vapor-diffusion method by mixing a 1:1 ratio of protein and reservoir solution containing 0.1 M Bis-Tris propane, 2% tacsimate and 20% (w/v) PEG 3350. DNA used for co-crystallization was purchased from Integrated DNA Technologies, Inc. For SRAPd_DPC structure, a 12-residue ssDNA containing a deoxyuridine (dU) at position 9 (5′-CCAGACGTUGTT-3′) was first incubated with UDG for 1 h at 37 °C, followed by heat treatment at 95 °C for 10 min to inactivate the enzyme. Reaction products were immediately extracted with phenol chloroform to remove the UDG enzyme. The abasic site containing ssDNA was then annealed with the complementary strand (5′-GTCTTG-3′) by mixing equal amounts at 95 °C, followed by cooling to room temperature. The UDG enzyme was purchased from New England BioLabs (catalog no. M0280L). SRAPd at 10 mg ml −1 was mixed, at a molar ratio of 1:1.2, with DNA containing site-specific abasic site and incubated for 0.5 h on ice. The mixture was then crystallized by setting 24-well vapor-diffusion sitting drops at room temperature, under conditions containing 20% (w/v) PEG 3350, 0.1 M KCl, 0.1 M Bis-Tris pH 5.5, 0.05 M MgCl 2 . Diffractionquality crystals were obtained by streak seeding the drops using a Hampton Research seeding tool (catalog no. HR8-133) with previously generated SRAPd_6nt crystals and incubating them at 20 °C for 1 week. SRAPd_DPC crystals were cryoprotected by using reservoir solution supplemented with 15% ethylene glycol and cryo-cooled in liquid nitrogen.
For SRAPd_3nt and SRAPd_6nt co-crystallization, purified SRAPd protein at 12 mg ml −1 was mixed, at a molar ratio of 1:1.2, with different 3′ overhang DNAs prepared by annealing equimolar amounts of two oligonucleotides, 5′-CCAGACGTT-3′ and 5′-GTCTTG-3′ for DNA_3nt; 5′-GTCTTG-3′ and 5′-CCAGACGTTGTT-3′ for DNA_6nt, and incubated for 0.5 h on ice. The mixture was then crystallized using the sitting-drop vapor-diffusion method under conditions containing 25% (w/v) PEG 3350, 0.2 M ammonium sulfate, 0.1 M HEPES pH 7.5 for SRAPd_3nt, and 20% (w/v) PEG 3350, 0.1 M KCl, 0.1 M Bis-Tris pH 5.5, 0.05 M MgCl 2 for SRAPd_6nt. Apo_SRAPd, SRAPd_3nt and SRAPd_6nt crystals were cryo-protected using reservoir solution supplemented with 20-30% glycerol and 20-30% ethylene glycol, respectively, and cryo-cooled in liquid nitrogen.
Diffraction data for Apo_SRAPd and SRAPd_DPC were collected at the 19ID and 24-ID-C beamlines of the Advanced Photon Source, respectively. Diffraction data for SRAPd_3nt and SRAPd_6nt were collected at the 5.0.1 beamline of the Advanced Light Source, Berkeley Laboratory. Datasets were processed with XDS 15 and merged with Aimless 16, 17 . Initial phases for the Apo_SRAPd were obtained by molecular replacement with Phaser-MR 18 , using a combination of models (PDB ID: 2F20, 2BDV, 2ICU, 1ZN6) generated by FFAS 19 . Initial phases for the SRAPd_3nt were obtained by molecular replacement with Phaser-MR 18 , using the Apo_SRAPd (PDB ID: 5KO9) as a search model. The initial phases for SRAPd_6nt and SRAPd_DPC were obtained by Fourier transform using SRAPd_3nt structure as a starting model. Models were built with COOT 20 and refined with refmac5 21 . Structures were validated with Molprobity 22 . Data collection and refinement statistics are shown in Table 1 . Figures were generated with PyMOL (http://pymol.org).
Fluorescence-based DNA-binding assay. All fluorescence polarization DNAbinding assays were performed in a final volume of 20 µl in a buffer containing 20 mM HEPES pH 7.4, 140 mM KCl, 5 mM NaCl, 0.1 mM EDTA, 0.01% Triton X-100 and 0.2 mM TCEP in 384-well black polypropylene PCR plates. Fluorescence polarization (mP) measurements were performed at room temperature using a BioTek Synergy 4 reader (BioTek). The K d values were calculated by fitting the curves in GraphPad Prism v.7.04 using non-linear regression, one site-specific binding. The sequences of 6-carboxyfluorescein-labeled DNA oligonucleotides are listed in (Supplementary Table 2 ). All DNAs were purchased from Integrated DNA Technologies, Inc.
LC-MS analyses of HMCES.
SRAPd was incubated with the abasic site containing 3′ overhang DNA (the same as used in SRAPd_DPC co-crystallization) at 1:1.2 ratio in a buffer containing 150 mM NaCl, 20 mM HEPES pH 7.5, 10 mM MgCl 2 at room temperature overnight. All LC-MS data were acquired according to the previously published protocol 23 on an Agilent 6545 Q-TOF equipped with a Dual Agilent Jet Stream ESI source coupled with an Agilent 1260 Infinity HPLC system. The analytical column utilized was a 300 StableBond Poroshell (Agilent, part number 883750-909) 2.1 × 100 mm 2 internal diameter reversed-phase C3 (5 μm particle size). The mobile phase (A) consisted of 97% HPLC-grade water with 0.5% formic acid and 2.5% acetonitrile, while the mobile phase (B) was 96% acetonitrile with 0.5% formic acid and 3.5% HPLC-grade water. A gradient profile was utilized at a flow rate of 500 μl min . The mobile phase was held for 2 min at 5% B (with eluant going to waste) and then switched to the mass spectrometer from 2 to 6 min, during which time solvent B increased from 5 to 95%. Two microliters of a 30-μM solution of each sample was injected. Raw data files were analyzed by Agilent MassHunter BioConfirm software (v.B.07.00). Mass spectra between 4 and 6 min were extracted, averaged and deconvoluted using the MaxEnt algorithm.
